Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fromm

Showing results (171-180 of 247) with videos related to

Pageof 25
Sort By:
Pharmacogenetics|July 4, 2001
The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cellsM Hitzl, S Drescher, H van der Kuip, et al.
Journal of Clinical Medicine|January 8, 2023
Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine DataWahram Andrikyan, Lea Jung-Poppe, Anna Altenbuchner, et al.
The Journal of Clinical Investigation|February 7, 1998
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitorsR B Kim, M F Fromm, C Wandel, et al.
Biochemical Pharmacology|August 28, 2010
Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1Kathrin Mandery, Krystyna Bujok, Ingrid Schmidt, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 13, 2002
Pharmacokinetics of intravenous etoposide in patients with breast cancer: influence of dose escalation and cyclophosphamide and doxorubicin coadministrationDagmar Busse, Gudrun Würthwein, Christiane Hinske, et al.
Molecular Pharmaceutics|December 26, 2015
The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3Shingen Misaka, Jana Knop, Katrin Singer, et al.
Clinical Chemistry and Laboratory Medicine|January 6, 2025
An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumorsNora Vogg, Eleanor North, Arne Gessner, et al.
Physical Review Letters|February 26, 2013
Localized states influence spin transport in epitaxial grapheneT Maassen, J J van den Berg, E H Huisman, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2016
Role of ABC and Solute Carrier Transporters in the Placental Transport of LamivudineMartina Ceckova, Josef Reznicek, Zuzana Ptackova, et al.
European Journal of Clinical Pharmacology|January 2, 2015
N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interactionFabian Müller, Constanza A Pontones, Bertold Renner, et al.
Pageof 25

Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
Pharmacogenetics|July 4, 2001
The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cellsM Hitzl, S Drescher, H van der Kuip, et al.
Journal of Clinical Medicine|January 8, 2023
Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine DataWahram Andrikyan, Lea Jung-Poppe, Anna Altenbuchner, et al.
The Journal of Clinical Investigation|February 7, 1998
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitorsR B Kim, M F Fromm, C Wandel, et al.
Biochemical Pharmacology|August 28, 2010
Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1Kathrin Mandery, Krystyna Bujok, Ingrid Schmidt, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 13, 2002
Pharmacokinetics of intravenous etoposide in patients with breast cancer: influence of dose escalation and cyclophosphamide and doxorubicin coadministrationDagmar Busse, Gudrun Würthwein, Christiane Hinske, et al.
Molecular Pharmaceutics|December 26, 2015
The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3Shingen Misaka, Jana Knop, Katrin Singer, et al.
Clinical Chemistry and Laboratory Medicine|January 6, 2025
An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumorsNora Vogg, Eleanor North, Arne Gessner, et al.
Physical Review Letters|February 26, 2013
Localized states influence spin transport in epitaxial grapheneT Maassen, J J van den Berg, E H Huisman, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2016
Role of ABC and Solute Carrier Transporters in the Placental Transport of LamivudineMartina Ceckova, Josef Reznicek, Zuzana Ptackova, et al.
European Journal of Clinical Pharmacology|January 2, 2015
N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interactionFabian Müller, Constanza A Pontones, Bertold Renner, et al.
Pageof 25